Literature DB >> 10544849

Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria.

M Mosca1, R Neri, S Bombardieri.   

Abstract

The connective tissue diseases include a heterogeneous group of conditions characterized by a wide variety of signs and symptoms. There also exists, however, a group of systemic autoimmune disorders with signs and symptoms not sufficiently evolved to fulfill any of the accepted classification criteria for the defined connective tissue diseases. These conditions have been defined as undifferentiated connective tissue syndromes, latent lupus, incomplete lupus, and undifferentiated connective tissue diseases. After an analysis of the existing literature, we discuss the possible significance of the undifferentiated diseases among the already defined connective tissue diseases and make a proposal for preliminary classification criteria for these conditions.

Entities:  

Mesh:

Year:  1999        PMID: 10544849

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  66 in total

1.  Lower-lobe shrinkage relative to total lung volume in collagen vascular diseases.

Authors:  M Watanabe; T Igishi; N Burioka; J Kurai; Y Fukuoka; K Kato; A Yamasaki; Y Hasegawa; R Okazaki; E Shimizu
Journal:  Radiol Med       Date:  2010-06-23       Impact factor: 3.469

2.  The value of pattern capillary changes and antibodies to predict the development of systemic sclerosis in patients with primary Raynaud's phenomenon.

Authors:  Slavica R Pavlov-Dolijanovic; Nemanja S Damjanov; Nada Z Vujasinovic Stupar; Snezana Baltic; Dragan D Babic
Journal:  Rheumatol Int       Date:  2013-08-11       Impact factor: 2.631

Review 3.  The Clinical Relevance of Anti-DFS70 Autoantibodies.

Authors:  Karsten Conrad; Nadja Röber; Luis E C Andrade; Michael Mahler
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

4.  [Optic atrophy, recurrent deterioration of vision and Raynaud's phenomenon].

Authors:  E Papageorgiou; U Schiefer; V Dörnberger; B Leo-Kottler
Journal:  Ophthalmologe       Date:  2008-08       Impact factor: 1.059

5.  Raynaud's phenomenon: prevalence in an Italian population sample.

Authors:  Rossella De Angelis; Fausto Salaffi; Walter Grassi
Journal:  Clin Rheumatol       Date:  2005-11-15       Impact factor: 2.980

6.  The impact of unrecognized autoimmune rheumatic diseases on the incidence of preeclampsia and fetal growth restriction: a longitudinal cohort study.

Authors:  Arsenio Spinillo; Fausta Beneventi; Elena Locatelli; Vèronique Ramoni; Roberto Caporali; Claudia Alpini; Giulia Albonico; Chiara Cavagnoli; Carlomaurizio Montecucco
Journal:  BMC Pregnancy Childbirth       Date:  2016-10-18       Impact factor: 3.007

7.  Severe thrombocytopenia in connective tissue diseases: a single-center review of 131 cases.

Authors:  Wei Zhang; Fan Wang; Hong Wang; Bingzhu Hua; Xuebing Feng; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2018-10-02       Impact factor: 2.980

Review 8.  An unusual case of undifferentiated connective tissue disease presenting as cardiac tamponade.

Authors:  Pawan Hari; Ashok Kondur; Palaniappan Manickam; Luis Afonso
Journal:  Rheumatol Int       Date:  2009-12-16       Impact factor: 2.631

9.  Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients.

Authors:  Katharina Hanke; Claudia S Brückner; Cornelia Dähnrich; Dörte Huscher; Lars Komorowski; Wolfgang Meyer; Anthonia Janssen; Marina Backhaus; Mike Becker; Angela Kill; Karl Egerer; Gerd R Burmester; Falk Hiepe; Wolfgang Schlumberger; Gabriela Riemekasten
Journal:  Arthritis Res Ther       Date:  2009-02-16       Impact factor: 5.156

10.  Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function.

Authors:  Brent W Kinder; Cyrus Shariat; Harold R Collard; Laura L Koth; Paul J Wolters; Jeffrey A Golden; Ralph J Panos; Talmadge E King
Journal:  Lung       Date:  2010-04       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.